GED-0507-34-Levo
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GED-0507-34-Levo, covering 2018-10-31 to 2018-10-31. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety Study of GED-0507-34-Levo for Treatment of UC [Phase 2]